Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation

Ying-Shan Zhu1, Taro Saito, Akiko Asada

  • 1Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, 1-1 Minami-osawa, Hachiohji, Tokyo, Japan.

Insights

Membrane interactions regulate Cyclin-dependent kinase 5 (Cdk5) activity. Cdk5-p35 kinase activity is low when bound to membranes, but increases upon solubilization, revealing a novel regulatory mechanism.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 5 (Cdk5) is crucial for neuronal functions.
  • Cdk5 activation typically requires binding to activators like p35 or p39.
  • Mechanisms regulating Cdk5 activity beyond activator binding are largely unknown.

Purpose of the Study:

  • To investigate the role of membrane interactions in regulating Cdk5-p35 complex activity.
  • To explore how membrane association affects the kinase function of Cdk5-p35.

Main Methods:

  • Analysis of Cdk5-p35 association with rat brain membranes.
  • Characterization of ionic and lipidic interactions with membranes.
  • Assessing kinase activity changes upon membrane solubilization using detergent or high-salt solutions.

Main Results:

  • Cdk5-p35 exhibits low kinase activity when associated with membranes.
  • Two distinct membrane association modes were identified: ionic (75%) and ionic plus lipidic (25%).
  • Solubilization reversibly increased Cdk5-p35 activity several-fold.

Conclusions:

  • Membrane interactions represent a novel regulatory mechanism for Cdk5-p35 kinase activity.
  • The level of membrane association influences Cdk5-p35 enzymatic function.
  • Understanding these interactions is key to Cdk5's role in neuronal processes and diseases.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...